Goodwin Procter and Ropes & Gray represented Anthos Therapeutics in the transaction. Novartis announced its acquisition of Anthos Therapeutics, Inc. for up to $3.1 billion. Under...
Novartis’ $3.1 Billion Acquisition of Anthos Therapeutics
Blackstone Life Sciences’ $750 Million Collaboration with Moderna
Ropes & Gray represented Blackstone Life Sciences in the transaction. Blackstone Life Sciences (NYSE:BX) (“Blackstone”) announced a collaboration with Moderna, Inc. (NASDAQ: MRNA, “Moderna”) through a development and...
Blackstone Life Sciences’ €300 Million Financing Collaboration with Sanofi
Goodwin advised Blackstone Life Sciences on the deal. Blackstone Life Sciences announced its strategic, risk-sharing financing collaboration with Sanofi, in which Blackstone will provide Sanofi with up...
Blackstone Life Sciences’ $250 Million Investment in Cellex Group
Noerr and Morgan, Lewis & Bockius advised Cellex Cell Professionals GmbH on the deal. Ropes & Gray advised Blackstone Life Sciences. The Dresden-based Cellex Group announced...




























